According to National Health Investors's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.60798. At the end of 2023 the company had a P/S ratio of 7.58.
Year | P/S ratio | Change |
---|---|---|
2023 | 7.58 | -6.93% |
2022 | 8.14 | -7.67% |
2021 | 8.82 | -5.12% |
2020 | 9.30 | -18.6% |
2019 | 11.4 | 4.32% |
2018 | 10.9 | -2.56% |
2017 | 11.2 | -5.53% |
2016 | 11.9 | 16.49% |
2015 | 10.2 | -30.9% |
2014 | 14.8 | -8.37% |
2013 | 16.1 | -4.39% |
2012 | 16.9 | 33.01% |
2011 | 12.7 | -20.8% |
2010 | 16.0 | -5.65% |
2009 | 17.0 | 40.32% |
2008 | 12.1 | |
2007 | N/A | -100% |
2006 | 6.08 | 7.14% |
2005 | 5.67 | 9.63% |
2004 | 5.17 | 27.42% |
2003 | 4.06 | 59.6% |
2002 | 2.54 | -16.97% |
2001 | 3.06 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
National Healthcare
NHC | 1.24 | -85.58% | ๐บ๐ธ USA |
Saul Centers BFS | 4.81 | -44.17% | ๐บ๐ธ USA |